Das D, Pemberton P W, Burrows P C, Gordon C, Smith A, McMahon R F, Warnes T W
The Liver Unit, Manchester Road Infirmary, Manchester, UK.
Biochim Biophys Acta. 2000 Nov 15;1502(3):351-62. doi: 10.1016/s0925-4439(00)00059-4.
Antioxidant and antifibrotic properties of colchicine were investigated in the carbon tetrachloride (CCl(4)) rat model. (1) The protective effect of colchicine pretreatment on CCl(4) induced oxidant stress was examined in rats subsequently receiving a single lethal dose of CCl(4). Urinary 8-isoprostane, kidney and liver malondialdehyde and kidney glutathione levels increased following CCl(4) treatment, but only the rise in kidney malondialdehyde was significantly inhibited by colchicine pretreatment. Serum total antioxidant levels were significantly higher in the colchicine pretreatment group. (2) The long term effects of colchicine treatment on CCl(4) induced liver damage were investigated using liver histology and biochemical markers (hydroxyproline and type III procollagen peptide). Co-administration of colchicine with sub-lethal doses of CCl(4) over 10 weeks did not prevent progression to cirrhosis. However, rats made cirrhotic with repeated CCl(4) challenge and subsequently treated with colchicine for 12 months, all showed histological regression of cirrhosis. (3) The antioxidant effect of colchicine in vitro was evident only at very high concentrations compared to other plasma antioxidants. In summary, colchicine has only weak antioxidant properties, but does afford some protection against oxidative stress; more importantly, long term treatment with this drug may be of value in producing regression of established cirrhosis.
在四氯化碳(CCl₄)大鼠模型中研究了秋水仙碱的抗氧化和抗纤维化特性。(1)在随后接受单次致死剂量CCl₄的大鼠中,检测了秋水仙碱预处理对CCl₄诱导的氧化应激的保护作用。CCl₄处理后,尿8-异前列腺素、肾和肝丙二醛以及肾谷胱甘肽水平升高,但只有肾丙二醛的升高被秋水仙碱预处理显著抑制。秋水仙碱预处理组的血清总抗氧化水平显著更高。(2)使用肝脏组织学和生化标志物(羟脯氨酸和III型前胶原肽)研究了秋水仙碱治疗对CCl₄诱导的肝损伤的长期影响。在10周内将秋水仙碱与亚致死剂量的CCl₄联合使用并不能阻止进展为肝硬化。然而,用反复CCl₄攻击诱导肝硬化并随后用秋水仙碱治疗12个月的大鼠,均显示出肝硬化的组织学消退。(3)与其他血浆抗氧化剂相比,秋水仙碱在体外的抗氧化作用仅在非常高的浓度下才明显。总之,秋水仙碱仅具有较弱的抗氧化特性,但确实能提供一些针对氧化应激的保护;更重要的是,长期使用这种药物可能对已形成的肝硬化的消退有价值。